openPR Logo
Press release

Anti-Thyroid Drugs Market Analysis, Current Trends, Technological Advancement, Size, Share And Competition Forecast To 2030

07-14-2021 10:46 AM CET | Health & Medicine

Press release from: The Business research company

Anti-Thyroid Drugs Market

Anti-Thyroid Drugs Market

The Business Research Company offers "Anti-Thyroid Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The anti-thyroid drugs market report describes and explains the global anti-thyroid drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Place A Direct Purchase Order Of The Report Here
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

The anti-thyroid drugs market consists of sales of anti-thyroid drugs and related services which are used for the treatment of hyperthyroidism. Hyperthyroidism is caused by over production of thyroid hormones in children, adults and pregnant women. Anti-thyroid class of drugs are also called thionamides which block the formation of thyroid hormone from over active thyroid gland.

The global anti-thyroid drugs market is expected to decline from $1.71 billion in 2020 to $1.5 billion in 2021 at a compound annual growth rate (CAGR) of -12.3%. The decline is mainly due to the companies rearranging their operations and recovering slowly from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anti-thyroid drugs market is expected to reach $1.73 billion in 2025 at a CAGR of 3.6%.

Request For The Sample Of Anti-Thyroid Drugs Market Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Some of the major players of anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co. and AbbVie, Inc.

The countries covered in the anti-thyroid drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The global anti-thyroid drugs market is segmented –
1) By Drug Type: Thionamides (inhibition of hormone synthesis), Iodides (inhibition of hormone release)
2) By Route of Administration: Oral, Intravenous, Others
3) By Distribution Channel: Wholesaler/Distributors, Retail Chain, Online Distribution, Others

Read More On The Global Anti-Thyroid Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Anti-Thyroid Drugs Market Characteristics
3. Anti-Thyroid Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Anti-Thyroid Drugs
5. Anti-Thyroid Drugs Market Size And Growth
....
26. Africa Anti-Thyroid Drugs Market
27. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles
28. Anti-Thyroid Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market
30. Anti-Thyroid Drugs Market Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.globalmarketmodel.com) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Thyroid Drugs Market Analysis, Current Trends, Technological Advancement, Size, Share And Competition Forecast To 2030 here

News-ID: 2328076 • Views: 263

More Releases from The Business research company

Power Bank Market Size, Analysis By Top Companies, And Forecast To 2022-2031 | A …
The global power bank market size is expected to grow from $13.19 billion in 2021 to $14.81 billion in 2022 at a compound annual growth rate (CAGR) of 12.3%. The change in the powerbank market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $21.98 billion in 2026
Microprocessor And GPU Market Size, Share, Analysis, Growth, Trends, Industry Re …
The global microprocessor and GPU market size is expected to grow from $86.78 billion in 2021 to $92.73 billion in 2022 at a compound annual growth rate (CAGR) of 6.9%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and
Instrument Transformers Market Report 2022 Market Size, Share, Demand, Growth Fa …
The global instrument transformers market size is expected to grow from $7.61 billion in 2021 to $8.17 billion in 2022 at a compound annual growth rate (CAGR) of 7.4%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the
Using The Global Market Model's "Pay-As-You-Go" Feature, You Can Browse Through …
The Global Market Model is a vast database that covers every industry in depth and can be accessed as required. We understand that it is not possible or needful to go through all the data at once. Hence, our GMM platform enables a "pay-as-you-go" model that is ideal for you, since you only pay for the information you utilize. The model allows you to choose the data you want to

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning